N/A
Completed N=167
A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk
Source: ClinicalTrials.gov NCT03416920 ↗Enrolled (actual)
167
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcomePrimary: Number of Participants With Readmission at 30 Days — 10 Participants
Summary
The investigators aim to evaluate Wellframe, a patient engagement platform that includes a mobile phone application for patients, for its impact on supporting patients who have undergone a percutaneous coronary intervention. The patient mobile app has articles about cardiovascular disease and other health related topics, patient-reported outcomes surveys, physical activity tracking, reminders for medications and upcoming appointments, and two-way communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages patients to achieve their health goals and stay engaged in their health. The feasibility of onboarding patients to the app and the clinical efficacy of the platform will be evaluated.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Readmission at 30 Days |
10 | — |
| SECONDARY Number of Participants With Readmission at 90 Days |
19 | — |
| SECONDARY Number of Participants Enrolled in Clinic-based Cardiac Rehab at 90 Days |
35 | — |
Eligibility Criteria
Inclusion Criteria
English-speaking PCI: balloon angioplasty, bare-metal stent, or drug-eluting stent at MGH Smartphone or Tablet (iOS or Android)
Exclusion Criteria
Recent (within 1mo) illicit substance use or alcohol abuse In-hospital AMI Known pregnancy Dementia or cognitive disability Incarceration
Data sourced from ClinicalTrials.gov (NCT03416920). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.